|A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate||
||1250||All||18 Years and older (Adult, Senior)||NCT00048568||IM101-102||December 2002||October 2009||October 2009||November 13, 2002||December 5, 2011||December 5, 2011||
|2||NCT00558506||Unknown †||Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis||
||Other / Industry||
||30||All||18 Years to 65 Years (Adult)||NCT00558506||ABATACEPT-AS-01||Aba-AS-01||January 2008||October 2009||December 2009||November 15, 2007||February 26, 2008||
† Study has passed its completion date and status has not been verified in more than two years.